| Trial Identifier: | D6060C00002 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT02705482 |
| Start Date: | March 2016 |
| Primary Completion Date: | August 2019 |
| Study Completion Date: | August 2019 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| Dutch Translation | |
| French Translation |
| Country | Location |
|---|---|
| France | Villejuif, France, 94805 |
| Netherlands | Amsterdam, Netherlands, 1081 HV |
| Netherlands | Amsterdam, Netherlands, 1066 CX |
| United States of America, CA | Santa Monica, CA, United States of America, 90404 |
| United States of America, IL | Chicago, IL, United States of America, 60611 |
| United States of America, MO | St Louis, MO, United States of America, 63110 |
| United States of America, NC | Huntersville, NC, United States of America, 28078 |
| United States of America, NM | Albuquerque, NM, United States of America, 87106 |
| United States of America, NY | New York, NY, United States of America, 10032 |
| United States of America, OR | Portland, OR, United States of America, 97213 |
| United States of America, TN | Nashville, TN, United States of America, 37203 |
| United States of America, TX | Houston, TX, United States of America, 77030 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company